Oropharyngeal candidiasis in immunocompromised children: A randomized, multicenter study of orally administered fluconazole suspension versus nystatin

The Journal of Pediatrics

Volumn 127, Issue 2, 1995, Pages 322-328

  Flynn, Patricia M ^a   Cunningham, Coleen K ^a   Kerkering, Thomas ^a   San Jorge, Antonia R ^a   Peters, Vicki B ^a   Pitel, Paul A ^a   Harris, JoAnn ^a   Gilbert, Gene ^a   Castagnaro, Lee ^a   Robinson, Patrick ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

FLUCONAZOLE; NYSTATIN;

ABDOMINAL PAIN; ADOLESCENT; ANOREXIA; ANTIFUNGAL ACTIVITY; ARTICLE; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG SAFETY; HEADACHE; HUMAN; INFANT; LIVER FUNCTION TEST; MAJOR CLINICAL STUDY; MULTICENTER STUDY; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RASH; RELAPSE; THRUSH;

ADMINISTRATION, ORAL; ADOLESCENT; CANDIDIASIS, ORAL; CHILD; CHILD, PRESCHOOL; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; FLUCONAZOLE; HIV INFECTIONS; HUMANS; IMMUNOCOMPROMISED HOST; IMMUNOSUPPRESSION; INFANT; NEOPLASMS; NYSTATIN; RECURRENCE;

EID: 0029147517     PISSN: 00223476     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-3476(95)70321-7     Document Type: Article

References (19)

1. Fungal infections complicating pediatric AIDS
2. Successful intermittent chemoprophylaxis for Pneumocystis carinii pneumonitis
3. Infections in cancer patients
4. Fluconazole and ketoconazole in the treatment of oral and esophageal candidiasis in AIDS patients
5. Therapy for oropharyngeal candidiasis in the immunocompromised host: a randomized double-blind study of fluconazole vs. ketoconazole
6. Assay of fluconazole by megabore capillary gas-liquid chromatography with nitrogen-selective detection
7. Fluconazole in the treatment of oropharyngeal candidosis in HIV-positive patients
8. Overview of studies of fluconazole in oropharyngeal candidiasis
9. Fungal flora of the normal human small and large intestine
10. Efficacy of oral fluconazole in the treatment of AIDS associated oesophageal candidiasis
11. Treatment of Candida albicans fungemia with fluconazole
12. Fluconazole-related hepatotoxicity in patients with acquired immunodeficiency syndrome
13. Fluconazole-induced jaundice
14. Emergence of Candida krusei infections after therapy of oropharyngeal candidiasis with fluconazole
15. Increase in Candida krusei infection among patients with bone marrow transplantation and neutropenia treated prophylactically with fluconazole
16. Failure of fluconazole to suppress fungemia in a patient with fever, neutropenia, and typhlitis
17. Fluconazole and Candida krusei fungemia
18. Prophylactic oral fluconazole and candida fungaemia